BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 30874320)

  • 21. Glutathione-S-transferase omega 1 (GSTO1-1) acts as mediator of signaling pathways involved in aflatoxin B1-induced apoptosis-autophagy crosstalk in macrophages.
    Paul S; Jakhar R; Bhardwaj M; Kang SC
    Free Radic Biol Med; 2015 Dec; 89():1218-30. PubMed ID: 26561775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Smoothened-independent activation of hedgehog signaling by rearranged during transfection promotes neuroblastoma cell proliferation and tumor growth.
    Ruan H; Luo H; Wang J; Ji X; Zhang Z; Wu J; Zhang X; Wu X
    Biochim Biophys Acta; 2016 Sep; 1860(9):1961-72. PubMed ID: 27316313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isozyme-specific fluorescent inhibitor of glutathione s-transferase omega 1.
    Son J; Lee JJ; Lee JS; Schüller A; Chang YT
    ACS Chem Biol; 2010 May; 5(5):449-53. PubMed ID: 20205472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
    Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
    Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
    Hong SK; Wu PK; Karkhanis M; Park JI
    Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.
    Watanabe R; Kurose T; Morishige Y; Fujimori K
    Neurochem Res; 2018 Feb; 43(2):488-499. PubMed ID: 29204750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The copper chaperone CCS facilitates copper binding to MEK1/2 to promote kinase activation.
    Grasso M; Bond GJ; Kim YJ; Boyd S; Matson Dzebo M; Valenzuela S; Tsang T; Schibrowsky NA; Alwan KB; Blackburn NJ; Burslem GM; Wittung-Stafshede P; Winkler DD; Marmorstein R; Brady DC
    J Biol Chem; 2021 Dec; 297(6):101314. PubMed ID: 34715128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholinergic stimulation of early growth response-1 DNA binding activity requires protein kinase C and mitogen-activated protein kinase kinase activation and is inhibited by sodium valproate in SH-SY5Y cells.
    Grimes CA; Jope RS
    J Neurochem; 1999 Oct; 73(4):1384-92. PubMed ID: 10501181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in early and late responses between neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y neuroblastoma cells.
    Edsjö A; Hallberg B; Fagerström S; Larsson C; Axelson H; Påhlman S
    Cell Growth Differ; 2001 Jan; 12(1):39-50. PubMed ID: 11205744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton.
    Harrison RE; Sikorski BA; Jongstra J
    J Cell Sci; 2004 Apr; 117(Pt 10):2151-7. PubMed ID: 15090600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MEK1/2 dual-specificity protein kinases: structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia.
    Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA
    Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of GM-CSF and M-CSF on tumor progression of lung cancer: roles of MEK1/ERK and AKT/PKB pathways.
    Uemura Y; Kobayashi M; Nakata H; Kubota T; Bandobashi K; Saito T; Taguchi H
    Int J Mol Med; 2006 Aug; 18(2):365-73. PubMed ID: 16820947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotection of miR-214 against isoflurane-induced neurotoxicity involves the PTEN/PI3K/Akt pathway in human neuroblastoma cell line SH-SY5Y.
    Wu Q; Shang Y; Shen T; Liu F; Xu Y; Wang H
    Arch Biochem Biophys; 2019 Dec; 678():108181. PubMed ID: 31704096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.
    Lahousse SA; Carter JJ; Xu XJ; Wands JR; de la Monte SM
    BMC Cell Biol; 2006 Dec; 7():41. PubMed ID: 17156427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cross-resistance to BRAFV600E-, MEK1/2- and PI3K/mTOR-specific inhibitors in BRAF-mutant melanoma cells counteracted by dual pathway blockade.
    Penna I; Molla A; Grazia G; Cleris L; Nicolini G; Perrone F; Picciani B; Del Vecchio M; de Braud F; Mortarini R; Anichini A
    Oncotarget; 2016 Jan; 7(4):3947-65. PubMed ID: 26678033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-β induces apoptosis in human SH-SY5Y neuroblastoma cells through activation of JAK-STAT signaling and down-regulation of PI3K/Akt pathway.
    Dedoni S; Olianas MC; Onali P
    J Neurochem; 2010 Dec; 115(6):1421-33. PubMed ID: 21044071
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin inhibits MEK1/2.
    Yamamoto T; Tsigelny IF; Götz AW; Howell SB
    Oncotarget; 2015 Sep; 6(27):23510-22. PubMed ID: 26155939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotoxicity induced by dexamethasone in the human neuroblastoma SH-SY5Y cell line can be prevented by folic acid.
    Budni J; Romero A; Molz S; Martín-de-Saavedra MD; Egea J; Del Barrio L; Tasca CI; Rodrigues AL; López MG
    Neuroscience; 2011 Sep; 190():346-53. PubMed ID: 21640799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S-(4-Nitrophenacyl)glutathione is a specific substrate for glutathione transferase omega 1-1.
    Board PG; Coggan M; Cappello J; Zhou H; Oakley AJ; Anders MW
    Anal Biochem; 2008 Mar; 374(1):25-30. PubMed ID: 18028863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.